As of 2026-04-18, the EV/EBITDA ratio of DarioHealth Corp (DRIO) is -1.75. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DRIO's latest enterprise value is 47.79 mil USD. DRIO's TTM EBITDA according to its financial statements is -27.25 mil USD. Dividing these 2 quantities gives us the above DRIO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 16.7x - 18.7x | 17.8x |
| Forward P/E multiples | 19.3x - 22.2x | 21.9x |
| Fair Price | (77.69) - (75.35) | (79.82) |
| Upside | -1170.1% - -1137.9% | -1199.5% |
| Date | EV/EBITDA |
| 2026-04-17 | -1.75 |
| 2026-04-16 | -1.70 |
| 2026-04-15 | -1.82 |
| 2026-04-14 | -1.83 |
| 2026-04-13 | -1.77 |
| 2026-04-10 | -1.75 |
| 2026-04-09 | -1.71 |
| 2026-04-08 | -1.64 |
| 2026-04-07 | -1.53 |
| 2026-04-06 | -1.85 |
| 2026-04-02 | -2.04 |
| 2026-04-01 | -1.96 |
| 2026-03-31 | -1.94 |
| 2026-03-30 | -1.98 |
| 2026-03-27 | -1.96 |
| 2026-03-26 | -2.05 |
| 2026-03-25 | -1.86 |
| 2026-03-24 | -1.88 |
| 2026-03-23 | -1.81 |
| 2026-03-20 | -1.93 |
| 2026-03-19 | -2.00 |
| 2026-03-18 | -2.17 |
| 2026-03-17 | -2.12 |
| 2026-03-16 | -2.04 |
| 2026-03-13 | -2.19 |
| 2026-03-12 | -2.21 |
| 2026-03-11 | -2.16 |
| 2026-03-10 | -2.22 |
| 2026-03-09 | -2.32 |
| 2026-03-06 | -2.36 |
| 2026-03-05 | -2.43 |
| 2026-03-04 | -2.28 |
| 2026-03-03 | -2.51 |
| 2026-03-02 | -2.62 |
| 2026-02-27 | -2.92 |
| 2026-02-26 | -2.74 |
| 2026-02-25 | -2.62 |
| 2026-02-23 | -2.75 |
| 2026-02-20 | -2.75 |
| 2026-02-19 | -2.79 |
| 2026-02-18 | -2.72 |
| 2026-02-17 | -2.82 |
| 2026-02-13 | -2.86 |
| 2026-02-12 | -2.74 |
| 2026-02-11 | -2.68 |
| 2026-02-10 | -2.51 |
| 2026-02-09 | -2.51 |
| 2026-02-06 | -2.42 |
| 2026-02-05 | -2.41 |
| 2026-02-04 | -2.47 |